Fredric N. Eshelman, Director, 10% Owner at G1 Therapeutics, Inc. (GTHX), bought 250,000 shares at $19.73 ($4.9M) on 2017-11-13, disclosed to the SEC on 2017-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| LQDA | SELL | 2021-01-21 | $872K | — | Filing → |
| LQDA | SELL | 2021-01-19 | $81K | — | Filing → |
| LQDA | SELL | 2021-01-15 | $219K | — | Filing → |